A new Yaz lawsuit was filed this week against Bayer Pharmaceuticals by a woman who alleges the popular birth control pill caused her to suffer pulmonary emboli and deep vein thrombosis (DVT), leaving her with permanent injuries.
Anna Butler of Kansas filed the product liability lawsuit in the U.S. District Court for the Eastern District of New York, which is at least the 75th federal lawsuit over Yaz or Yasmin oral contraceptives.
Butler took Yaz from April 2006 through August 2007, when she had bilateral pulmonary emboli and deep vein thrombosis. She is suing Bayer and its subsidiary, Berlex Laboratories, for negligence in creating a defective product and fraud in trying to conceal knowledge of the potential Yaz side effects. The lawsuit seeks compensation for treatment of her injuries, pain, suffering and emotional distress.
A lawsuit was filed on September 18 by Candice Richardson in the U.S. District Court for the Eastern District of Texas, alleging that a blood clot from Yaz and Yasmin use caused her to lose her unborn daughter during the 27th week of pregnancy.
According to the Southeast Texas Record, Richardson took the birth control pills before she became pregnant, which she alleges increased her risk of suffering blood clots during.
Nearly identical Yasmin lawsuits and Yaz lawsuits have been filed throughout the United States in both state and federal courts on behalf of hundreds of women who allege that they suffered injuries as a result of Bayer’s failure to warn about the health problems with Yaz and Yasmin.
Cases have been filed over blood clots, heart attacks, strokes, pulmonary emboli, deep vein thromboses, gallbladder disease and sudden death on Yaz or Yasmin.
Two recent studies, one by researchers in Denmark and one by researchers in The Netherlands, found that birth control pills like Yaz, Yasmin and Ocella, which contain drospirenone, are more likely to cause blood clots than oral contraceptives that contain other forms of progestin, including older progestins such as levonorgestrel.
Last week, the U.S. Judicial Panel on Multidistrict Litigation heard testimony from plaintiffs and defendants on whether to consolidate and centralize all federal Yaz and Yasmin lawsuits under one judge as part of an MDL, or Multidistrict Litigation, for pretrial litigation. A decision is expected in coming weeks.
The two FEDERAL COURT options being requested is either the Northern District of Ohio or the Southern District of Illinois.
There is a State Consolidation for cases filed in PA, in Philadelphia.
If you or a family member has been personally injured because of the fault of someone else: by the use of dangerous and defective drugs, bad products, or toxic injury etc then please contact the Fort Worth Texas Defective Drugs Product Liability Attorney Dr. Shezad Malik. For a no obligation, free case analysis, please call 817-255-4001 or Contact Me Online.
The Dr. Shezad Malik Law is currently evaluating and accepting Yaz, Yasmin and Ocella Side Effect cases.
Legal News, Yaz, attorney yasmine, attorney yaz, birth control yasmin, birth control yaz, blood clots, contraceptive, dallas yasmine attorney, dallas yasmine law firm, dallas yaz attorney, dallas yaz law firm, deep vein thrombosis, drospirenone, gallbladder damage, increase potassium level, increased potassium levels, lawyer yasmine, lawyer yaz, oral contraceptive, pulmonary embolism, side effects of yasmin, side effects of yaz, side effects yasmin, side effects yaz, yasmin, yasmin birth control, yasmin side effects, yasmine attorney, yasmine law firm, yasmine lawsuit, yasmine lawyer, yaz attorney, yaz birth control, yaz law firm, yaz lawsuit, yaz lawyer, yaz side effects
attorney attorneys Bayer Bayer HealthCare blood clots cardiac arrest cardiac arrhythmia class action contraceptive deep vein thrombosis drospirenone elevated potassium FDA FDA testing gallbladder disease gall bladder disease heart attack lawsuit lawsuits litigation Texas oral contraceptive Pennsylvania Pennsylvania lawsuit Philadelphia Philadelphia Court of Common Pleas PMDD PMS potassium premenstrual dysphoric disorder pulmonary embolism strokes U.S. Food & Drug Administration Yasmin Yaz Yaz class action Yaz lawsuit